// App-Quantinova.ai

NIMG-40 : RAPID EARLY PROGRESSION (REP) OF GLIOBLASTOMA IS AN INDEPENDENT NEGATIVE PROGNOSTIC FACTOR: RESULTS FROM A SYSTEMATIC REVIEW AND META-ANALYSIS

Researchers

Presenter

  • Mueez Waqar

Principal Investigators

  • Federico Roncaroli

  • Eric Lehrer

  • Joshua Palmer

  • Javier Villanueva-Meyer

  • Steve Braunstein

  • Emma Hall

  • Marianne Aznar

  • Philip Witt De Hamer

  • Pietro D'Urso

  • Daniel Trifiletti

  • Alfredo Quinones-Hinojosa

  • Pieter Wesseling

  • Gerben Borst

Medical Centers

  • University of California, San Francisco, San Francisco, CA

  • The Department of Radiation Oncology, The James Cancer Hospital, Ohio State University Wexner Medical Center, Columbus, OH, USA

  • Icahn School of Medicine at Mount Sinai, New York, NY, USA

  • Salford Royal, Manchester, United Kingdom

  • Mayo Clinic, Jacksonville, FL, USA

  • UCSF, San Francisco, USA

  • Amsterdam University Medical Centers, Amsterdam, Netherlands

  • Department of Neurological Surgery, Mayo Clinic, Jacksonville, FL, USA

  • University of Manchester, Manchester, United Kingdom

  • The Christie, Manchester, United Kingdom

Locations

  • United States

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Glioblastoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved